Praised for its ‘deep insight’ into life sciences regulation, Setterwalls’ practice handles the full gamut of SPC and patent issues, M&A, and capital markets mandates within the sector. Per Lidman leads the team from Malmö with his longstanding experience in pharma patent litigation, distribution, and licensing issue. Regulatory specialist Helena Nilsson is well placed to advise on clinical studies, market access, and classification-focused mandates, while Martin Levinsohn is recommended for his broad experience encompassing infringement and revocation actions, in addition to competition-focused mandates.
L’éditorial du Legal 500
Témoignages
Collectés indépendamment par l'équipe de recherche du Legal 500.
‘Very pragmatic. Direct, to the point, friendly professional people.’
‘Great team with deep insight into life sciences regulation.’
‘Helena Nilsson knows the regulatory work in detail. Lovisa Dahl Nelson is a great IP lawyer.’
‘Very agile team as well as very knowledgeable. Someone to hold hands with when problems arise. Feels truly like an internal legal department!! Covers a wide range of special knowledge within the life sciences industry so it is truly a one-stop-shop when approaching the Setterwalls life sciences team.’
‘The team's response is very quick and it very quickly and professionally gets a very good grip of the situation, and knows how to act and react in different situations.’
‘Excellent knowledge of local law and practice, availability, counsel on litigation, patent invalidation and on practical and strategic aspects linked to the Swedish law.’
‘Martin Levinsohn and Karolina Jivebäck Pap: in addition to their outstanding knowledge of the sector and of local law, they have provided advice in a timely and clear manner, with strategic outlook and full discussion of the possible scenarios.’
Clients clés
- Abacus Medicine
- Accord Healthcare
- Apoteksgruppen i Borrby nr 1 AB
- Barry Callebaut
- Blodtrycksdoktorn
- Coala Life
- Doktorse Nordic
- Gbosco AB
- Move & Walk Sverige AB
- Cloetta
Points forts
- Assisting KKR in connection with the acquisition of Immedica Pharma. The investment is made through KKR Health Care Strategic Growth Fund II.
- Advised Navamedic on an IP licensing and distribution arrangement with Orion Corporation concerning Flexilev in Europe.
- Representing Sandoz in a patent dispute with Bayer concerning Bayer’s patent for a once-daily dosing regimen for the active ingredient rivaroxaban, which is a pharmaceutical used in the prevention and treatment of thromboembolism.
Avocats
Les grands avocats du marché
Avocats associés reconnus parmi les leaders du marché par leurs pairs et leurs clients, régulièrement présents dans les grands dossiers dans lesquels ils sont au premier plan.
Responsable de la pratique
Per Lidman
Autres avocats clés
Helena Nilsson; Martin Levinsohn; Marcus Nivinger; Niklas Follin; Karolina Jivebäck Pap; Lovisa Dahl Nelson